Research programme: MCP1 splice variant - Compugen

Drug Profile

Research programme: MCP1 splice variant - Compugen

Alternative Names: CGEN-54; Research programme: monocyte chemoattractant protein 1 splice variant - Compugen

Latest Information Update: 03 Sep 2009

Price : $50

At a glance

  • Originator Compugen
  • Class
  • Mechanism of Action CCR2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Suspended Inflammation

Most Recent Events

  • 01 Nov 2006 Preclinical trials in Inflammation in Israel (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top